Background
==========

The nematode *Caenorhabditis elegans*, which is a well-established model organism for biomedical research \[[@B1]\], is the first metazoan whose genome was subject to whole-genome sequencing \[[@B2]\]. Its gene models were first predicted using the gene prediction program Genefinder (P. Green, unpublished). Over the dozen years since the completion of the *C. elegans*genome sequencing project \[[@B2]\], the *C. elegans*gene set has been curated by the *C. elegans*research community and by WormBase curators \[[@B1],[@B3]-[@B5]\]. However, the *C. elegans*gene set is still far from complete for the following reasons: First, because Genefinder, like other gene prediction programs, was developed based on an incomplete understanding of gene structures, it suffers from both false positive and false negative predictions; second, many *bona fide*genes, especially those of unknown character, have been missed. In WormBase <http://www.wormbase.org>, the official database for the biology and genomics of *C. elegans*, less than 40% of the annotated gene models are fully confirmed. All others are either partially supported or not supported at all. Additional gene models have been revealed in transcriptome sequencing \[[@B6],[@B7]\], suggesting many gene models remain to be discovered. This situation is also true for other species \[[@B8]\]. In the human genome, it has been estimated that the most accurate programs only correctly predict 40% of the annotated genes \[[@B9]\].

In this project, we explored how to reconstruct full-length gene models for genes that are not correctly represented in the current gene set, using expressed sequence tags obtained in large-scale gene expression projects. In particular, we attempted to reconstruct novel *C. elegans*gene models using SAGE (serial analysis of gene expression). The SAGE technique was originally developed for profiling gene expression \[[@B10],[@B11]\]. The expression profiles created with SAGE have a wide range of applications that include therapeutic target identification in cancerous tissues \[[@B12]\] and others of biological and medical importance \[[@B13]\]. Recently, SAGE was applied to probe gene expression in *C. elegans*by the *C. elegans*Gene Expression Consortium <http://elegans.bcgsc.bc.ca/home/ge_consortium.html>. These SAGE libraries have been fundamental for the success of a variety of research projects \[[@B14]-[@B19]\]. While SAGE tags that correspond to existing gene models can be used to evaluate the abundance of gene expression, there are a large number of SAGE tags that do not correspond to existing gene models. These SAGE tags suggest the existence of additional coding exons, splice variants \[[@B20]\], or novel genes.

Results
=======

Tag based reconstruction of full-length cDNA sequence of novel genes
--------------------------------------------------------------------

Expressed sequence tags that cannot be aligned to the *C. elegans*virtual transcriptome (i.e., cDNA sequences of all annotated transcripts) suggest the existence of yet unannotated genes \[[@B13],[@B21]\]. We have established a protocol, termed as \"sequence *t*ag-based *a*mplification of *c*DNA *e*nds\", or STACE, based on the RACE protocol \[[@B22]\], to identify potential novel genes. The method can be used to amplify full-length cDNA transcripts that have been reverse-transcribed from the mRNA sequence of novel genes. STACE uses three primer hybridization sites. The first site (the 5\' site) is a sequence located at the extreme 5\' end of the target transcript, the second site (the 3\' site) is downstream of the polyadenylation sequence, and the third site (the gene-specific site) corresponds to the genomic span where the uncharacterized tag maps. The amplicons are then cloned, sequenced and mapped to the genome. As such, STACE not only confirms the existence of a novel gene, but also defines the full-length transcript sequence of the yet undefined gene.

In this project, in order to get a primer hybridization site at the extreme 5\' end of the RNA transcripts, we took advantage of the trans-splice leader 1 (SL1) in *C. elegans*, and used its sequence as a primer for our 5\' site. It is appropriate to design the 5\' primer based on the SL1 sequence because SL1 is trans-spliced to the extreme 5\' end of nearly 50% of all *C. elegans*mRNAs \[[@B23],[@B24]\]. For applications in which the sample transcriptome does not undergo trans-splicing of this nature, a common oligo anchoring sequence can be ligated to the 5\'end of each transcript. An oligo sequence was attached to the polyadenylation tracks of mRNA through reverse transcription with a modified oligo d(T) primer that included a 3\' common sequence (5\' - CCAGACACTATGCTCATACGACGCAGT~(16)~VN - 3\'). This provided us with a cDNA library containing transcripts that had a usable 3\' site. Finally, we chose gene-specific sites by bioinformatically identifying SAGE tags. When aligned to the *C. elegans*genome, qualified SAGE tags do not overlap with existing gene models. For each qualified SAGE tag, a primer was designed and used in conjunction with a primer complementary to the SL1 sequence to amplify the upstream amplicon. A second primer was designed and used in conjunction with the primer complementary to the 3\' common sequence (above) to amplify the downstream amplicon. The potential template was amplified, and the amplicon sequences were mapped to the *C. elegans*genome using BLAT \[[@B25]\], which is available at WormBase <http://www.wormbase.org>.

Computational selection of SAGE tags that suggest novel genes
-------------------------------------------------------------

SAGE tags used in this study were selected from 33 SAGE libraries, which were sequenced from different tissues and developmental stages of *C. elegans*<http://tock.bcgsc.bc.ca/cgi-bin/sage160>. There are altogether 220,770 unique SAGE tags in these libraries. Only SAGE tags that did not overlap with annotated protein-coding genes in the WS160 version of the *C. elegans*genome map were selected for this project.

We obtained four different sets of SAGE tags for testing, one preliminary set and three test sets (Set 1-3) (Table [1](#T1){ref-type="table"}). The preliminary set, which was arbitrarily chosen, was used to test the STACE protocol. Set 1 used a longSAGE meta-library as a starting tag set (16,587 SAGE tags). Set 2 was created from the WS160 version of the mixed stage library (14,701), and Set 3 used SAGE libraries derived from Solexa sequencing of the SWN21 and SWN22 embryonic samples (359,457 SAGE tags). Solexa SAGE produced more initial SAGE tags than the previous SAGE libraries because it has much deeper coverage. Note that the Illumina Solexa Genome Analyzer produced a SAGE library that is about 20 times more sensitive than a normal SAGE library \[[@B26]\].

###### 

SAGE tag numbers for each set through the identification of high value candidate SAGE tags.

            *Total tags*   *Mappable tags*   *Non-transcriptome tags*   *Tags with frequency count \>3*   *Tags absent from gene boundaries and introns*   *Tags with appropriate GC content*   *Tags that can serve as primers*   *SAGE tag primers tested*
  --------- -------------- ----------------- -------------------------- --------------------------------- ------------------------------------------------ ------------------------------------ ---------------------------------- ---------------------------
  *Set 1*   16,587         13,743            3,052                      616                               418                                              128                                  39                                 30
                                                                                                                                                                                                                                   
  *Set 2*   14,701         10,534            4,755                      365                               41\*                                             19                                   12                                 12
                                                                                                                                                                                                                                   
  *Set 3*   359,457        32,416            13,542                     8,211                             469                                              124                                  106                                96

SAGE libraries were filtered to select SAGE tags for finding novel genes (Figure [1](#F1){ref-type="fig"}). The criteria used included the following: (1) Only SAGE tags that can be aligned to the *C. elegans*genome were selected; (2) The SAGE tags must not overlap with any annotated coding exon; (3) To avoid tags containing sequencing errors, SAGE tags must have a frequency of at least three for every 100,000 reads; (4) To increase the chances of finding novel genes (rather than novel missing exons), the SAGE tags must not overlap with an intron and have to be at least 500 bp away from an annotated 5\' or 3\' gene boundary; (5) SAGE tags must have a GC content between 35% and 45%, which is critical for primer design.

![**SAGE tag primer development**. SAGE tag pools are put through various filtrations to produce a source of SAGE tag primers that are used in STACE experiments. 1) SAGE tag libraries are downloaded from the MultiSAGE website. 2) All SAGE tags that do not fully map to the genome as one single uninterrupted alignment are discarded. 3) SAGE tags that map to annotated transcribed sequences are discarded. 4) SAGE tags that have a low level of expression and are possible errors in sequencing are discarded. 5) SAGE tags that are found to overlap with intronic sequences or map near a 5\' or 3\' boundary are eliminated. 6) Only tags with GC content between 35% and 45% are retained. 7) SAGE tags are edited into primer form. All SAGE tags that are likely to produce secondary structure (i.e. hairpins, homo-dimers, hetero-dimers) are discarded. 8) A final list of SAGE tag primers is procured.](1471-2199-11-96-1){#F1}

Primers based on SAGE tags were designed to ensure a reduced possibility of formation of secondary structures which would inhibit proper annealing of the primers \[[@B27]\]. For many cases, we trimmed sequences from either end of the SAGE tags to ensure primer quality. SAGE tag sequences that could not be used to guide proper primer design were not used. Primer design was done using the Primer3 program \[[@B28]\].

cDNA libraries
--------------

Two different cDNA libraries were created; one from a mixed stage population of *C. elegans*and another one from embryonic animals. In order to maximize the number of successful experiments, candidate SAGE tags were only screened against the developmental library that corresponded with the time in development that the tags were originally observed.

New transcripts and novel cDNAs
-------------------------------

STACE-identified candidates consist of three categories based on the alignments of these candidates to the *C. elegans*genome (release WS160): (1) novel gene (six candidates), (2) annotation extension (four candidates), and (3) non-protein-coding gene overlap (two candidates) (Figure [2](#F2){ref-type="fig"}; Table [2](#T2){ref-type="table"}). Novel genes are proof of entirely new genes discovered using the STACE method. The exons of these six new genes are all bordered by the canonical GT-AG splice signals, as is the case with most exons \[[@B29],[@B30]\]. Our identification of six novel genes was based on using the WS160 annotated genome. In the interim four have been annotated in WS200, while the other two are still completely novel. One of these two new gene models was characterized as a full-length gene model with the STACE method, while the other\'s existence was implied by an upstream amplicon sequence. Four tested SAGE tag primers produced results that suggest an extension to the annotated length of the gene models. These annotated extensions align perfectly with annotated exons, and imply either additional exons are transcribed within the gene, or that the terminal exons are longer than shown by WormBase.

![**STACE experimental procedure**. Template cDNA is used in two separate PCR reactions that utilize primers based on the sequence of a SAGE tag, the SL1 sequence and modified oligo d(T) primer. The PCRs produce an amplicon representative of the sequence upstream of the SAGE tag location (PCR product 1), and another that comes from the downstream sequence (PCR product 2). These products are sequenced, and mapped to the *C. elegans*genome. Those sequences whose alignments overlap with the SAGE tag used in primer design are considered true positive STACE results.](1471-2199-11-96-2){#F2}

###### 

Result classifications for all sets of tested SAGE tag primers.

                    Novel Genes   Annotation Extensions   Non-Protein Gene Overlap   Number of Candidate cDNAs/Number of SAGE tag Primers Tested
  ----------------- ------------- ----------------------- -------------------------- -------------------------------------------------------------
  Preliminary Set   1             0                       2                          3/6 (50%)
                                                                                     
  Set 1             3             1                       0                          4/30 (13%)
                                                                                     
  Set 2             0             2                       0                          2/12 (17%)
                                                                                     
  Set 3             2             1                       0                          3/96 (3%)
                                                                                     
  Total             6             4                       2                          12/144 (8%)

We found a successful STACE result overlapped with a pseudogene. While this transcript may not be translated, using STACE we have clearly shown that it is processed with introns removed and a polyadenylation track added to the 3\'end. We have also found that a STACE result overlapped with an annotated ncRNA gene. The transcript was also processed with a previously unknown intron excised and a polyadenylation track added.

Altogether, we have reconstructed seven full-length, true positive cDNA sequences, corresponding to seven separate gene models (Table [3](#T3){ref-type="table"}). All seven cDNAs contain SL1 signals at the 5\' ends and polyadenylation at the 3\'ends. The remaining seven true positive cDNAs recovered represent the 5\'ends of separate gene models, and these too contain full-length 5\' SL1 signals. Thus, in this study, we have identified 14 SL1-trans-spliced cDNA sequences. All 14 cDNA sequences have been submitted to GenBank (Table [3](#T3){ref-type="table"}).

###### 

Identified cDNA sequences from Set 3 STACE experiments.

  *Result*               *SAGE tag primer*       *SAGE tag location*   *Sequence 5\' mapping boundary*   *Sequence 3\' mapping boundary*   *GenBank accession number*   *Status (as of WS200)*
  ---------------------- ----------------------- --------------------- --------------------------------- --------------------------------- ---------------------------- -------------------------------------------------------------------------
  Full-length cDNA P.1   GTTAGGATCGTAGAGGACATG   II:8786920            II:8786297                        II: 8787044                       [HQ451870](HQ451870)         Overlaps F07H5.4 (pseudogene): evidence for extension to annotated exon
                                                                                                                                                                        
  Partial cDNA P.2       AGAGGATTAATTCCCCCCATG   II:9375813            II:9376228                        II:9375792                        [HQ451877](HQ451877)         Overlaps with C06C3.10
                                                                                                                                                                        
  Full-length cDNA P.3   GGGGGAAAATCGAAAGACATG   II:10201160           II: 10202155                      II:10201084                       [HQ451871](HQ451871)         Overlaps with tts-2 (ncRNA): evidence for new intron
                                                                                                                                                                        
  Partial cDNA 1.1       GAAACGAAGAAGAAAAGCATG   V:19434698            V:19434352                        V:19434718                        [HQ451878](HQ451878)         Evidence of a novel gene
                                                                                                                                                                        
  Full-length cDNA 1.2   TTCGACGGCAGATTGTTCATG   V:19432707            V:19433037                        V:19432406                        [HQ451872](HQ451872)         Overlaps with C25F9.11: evidence for new 5\' UTR
                                                                                                                                                                        
  Full-length 1.3        TAGCTCAGTCAAAACAACATG   V:5812559             V:5813070                         V:5812296                         [HQ451873](HQ451873)         Overlaps with ZC250.4: evidence for extension to 3\' UTR
                                                                                                                                                                        
  Partial cDNA 1.4a      AAAGTTGAGCTTCTGCTCATG   X:2346863             X:2335678                         X:2346883                         [HQ451879](HQ451879)         Overlaps with T01B6.1: evidence for new coding sequence
                                                                                                                                                                        
  Partial cDNA 1.4b      AAAGTTGAGCTTCTGCTCATG   X:2346863             X:2345479                         X:2346883                         [HQ451880](HQ451880)         Overlaps with T01B6.1: evidence for new transcriptional start site
                                                                                                                                                                        
  Partial cDNA 2.1a      TGGTTGTTAGTAGTGTACATG   II:15229391           II:15207408                       II:15229412                       [HQ451881](HQ451881)         Overlaps with Y46E12BL.4: evidence for new 3\' UTR exon
                                                                                                                                                                        
  Partial cDNA 2.1b      TGGTTGTTAGTAGTGTACATG   II:15229391           II:15216289                       II:15229412                       [HQ451882](HQ451882)         Overlaps with Y46E12BL.4: evidence for new initial coding exon
                                                                                                                                                                        
  Full-length cDNA 2.2   CCATCTAAAGGGCTCTACA     IV:4415359            IV:44085996                       IV:4415616                        [HQ451874](HQ451874)         Overlaps with Y24D9A.1: evidence for extension to 3\' UTR
                                                                                                                                                                        
  Full-length cDNA 3.1   CTCATTGAAGGTGAAGCAT     X:14690913            X:14692920                        X:14690763                        [HQ451875](HQ451875)         Overlaps with sox-3: evidence for new 3\' UTR
                                                                                                                                                                        
  Partial cDNA 3.2       TGAAATGTCACAGTACACAT    III:7604002           III: 7601399                      III:7604022                       [HQ451883](HQ451883)         Evidence of a novel gene
                                                                                                                                                                        
  Full-length cDNA 3.3   GAGAGAATTGTTGTGACCAT    X:4681136             X:4682689                         X:4680952                         [HQ451876](HQ451876)         Evidence of a novel gene

All data is current as of WS200.

Discussion
==========

In this project, we have developed an experimental method termed STACE for reconstructing full-length cDNAs of novel genes. The applicability of STACE has been demonstrated by defining novel genes in the well-curated *C. elegans*genome, using SAGE tags from gene expression studies. We reconstructed seven novel full-length cDNAs and seven partial cDNA sequences that can be merged to existing gene models. Novel genes, annotation extensions, and non-protein-coding gene overlaps are represented by the identified cDNA sequences 3.3 (Figure [3](#F3){ref-type="fig"}), 3.1 (Figure [4](#F4){ref-type="fig"}), and P.3 (Figure [5](#F5){ref-type="fig"}), respectively.

![**Candidate cDNA 3.3 alignment**. Full length gene model reconstructed for candidate cDNA 3.3. This gene model suggests a completely novel gene that is missing from WormBase as of WS200.](1471-2199-11-96-3){#F3}

![**Candidate DNA 3.1 alignment**. Full length gene model reconstructed for candidate cDNA 3.1. This gene model suggests a 3\' UTR extension to the current sox-3 gene model.](1471-2199-11-96-4){#F4}

![**Candidate cDNA P.3 alignment**. Full length gene model reconstructed for candidate cDNA P.3. This gene model suggests revision of the structure to the tts-2 gene model, and also that this transcript is polyadenylated, a feature that is commonly associated with protein-coding genes.](1471-2199-11-96-5){#F5}

We compared novel cDNAs with *C. elegans*gene models predicted using AUGUSTUS \[[@B31]\], mGENE \[[@B32]\], TWINSCAN \[[@B33]\] and FGENESH++ \[[@B34]\], which are available at WormBase. All cDNAs, which were detected using STACE, when aligned to the *C. elegans*genome overlap to a certain extent with predicted gene models. The novel full-length cDNA 3.3 aligned well with a prediction from TWINSCAN and with a prediction made by FGENESH++. The annotation extension result (full-length cDNA 3.1) was found to overlap with gene predictions from each of the utilized programs. However, a new 3\' UTR exon was shown to be part of this gene model, and this exon did not overlap with the predictions made by any of the described programs. Additionally, the P.3 result overlapped with an existing ncRNA gene model. However, the novel intron suggested by this STACE result was not included in the WormBase gene model, although it overlaps with AUGUSTUS prediction.

Conclusions
===========

We have found that the STACE method can be used to recover accurate full-length gene models. This method is useful for reconstructing gene models for genes that have been missed in cDNA sequencing projects and were missed or mispredicted by gene finders. With the wide application of next-generation sequencing methods in the deep sequencing of transcriptomes, more expressed sequence tags, which indicate the presence of novel genes will be uncovered. We expect that these tags will serve as input to the STACE protocol for further novel gene discovery and determination.

Methods
=======

cDNA library production
-----------------------

Two samples of *C. elegans*were produced that represented both a mixed stage population and an embryonic sample. Tissue samples were put through an RNA extraction using TRIzol (Invitrogen, SKU\# 10296-028). The cDNA libraries used in this project were created with the Superscript III reverse transcriptase kit (Invitrogen, SKU\# 18080-085), and the primer used to initiate reverse transcription was a modified oligo d(T) primer (5\' - CCAGACACTATGCTCATACGACGCAGT~(16)~VN - 3\') (Invitrogen). The protocol accompanying the kit was followed, and the samples were treated with Ribonuclease H (Invitrogen, SKU\# 18021-014).

Amplification of tag ends
-------------------------

The reverse complement of each SAGE tag sequence was used to design the SAGE tag primers. These primers were used in conjunction with a primer based on the SL1 sequence (5\' - GGTTTAATTACCCAAGTTTGAG - 3\') in a PCR. The PCR was initiated with a 94°C melt step for 2 minutes, followed by 32 cycles of a 94°C melt step for 15 seconds, a 60°C annealing step for 45 seconds, and a 72°C extension step for 1 minute. This was followed by a final extension at 72°C for 5 minutes. A Taq polymerase provided by Dr. Harald Hutter was used in all of the PCRs. Amplicons produced by the PCRs were visualized with a 1% gel electrophoresis, and extracted with a QIAquick Gel Extraction kit (Qiagen, ID 28704). These amplicons were then cloned with the InsTAclone kit (Fermentas, \#K1214). Cloned amplicons were submitted for sequencing (Macrogen, Seoul, Korea), and returned sequences were mapped back to the *C. elegans*genome with the BLAT tool \[[@B25]\] on the WormBase website <http://www.wormbase.org/>. We opted to use BLAT instead of other alignment tools because this program can take spliced mRNA sequences (i.e. STACE cloned sequences) and align them to the genome in a way that reflects intron - exon boundaries \[[@B25],[@B35]\]. Those amplicons whose sequence alignment indicated a true positive result were then further studied. The returned sequence was used to design an internal primer that would be compatible with the universal primer (5\' - CACTATGCTCATACGACGCAGT - 3\'). These primers were then used in a PCR with the same parameters described above to produce the downstream amplicons needed for full-length characterization. Internal primers were designed using the Primer3 program \[[@B28]\].
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